$3.33 Billion is the total value of Alphabet Inc.'s 27 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UBER | Uber Technologies Inc | $2,167,586,000 | -34.3% | 71,138,345 | 0.0% | 65.12% | +4.0% | |
| LYFT | Lyft Inc | $523,935,000 | -37.8% | 12,828,964 | 0.0% | 15.74% | -1.6% | |
| JD | JD com Incspon adr cl a | $382,344,000 | -6.9% | 13,553,474 | 0.0% | 11.49% | +47.5% | |
| RCUS | Arcus Biosciences Inc | $45,953,000 | +14.5% | 5,049,786 | 0.0% | 1.38% | +81.2% | |
| MGTA | Magenta Therapeutics Inc | $34,260,000 | -30.4% | 3,339,138 | 0.0% | 1.03% | +10.2% | |
| WORK | Sell | Slack Technologies Inc. | $30,844,000 | -93.2% | 1,299,771 | -89.3% | 0.93% | -89.2% |
| NET | New | Cloudflare Inc | $30,316,000 | – | 1,632,519 | +100.0% | 0.91% | – |
| DXCM | Dexcom Inc | $16,485,000 | -0.4% | 110,457 | 0.0% | 0.50% | +57.6% | |
| SPRO | Spero Therapeutics Inc | $11,792,000 | -7.9% | 1,112,473 | 0.0% | 0.35% | +45.7% | |
| FTSV | Forty Seven Inc | $9,925,000 | -39.4% | 1,545,966 | 0.0% | 0.30% | -4.2% | |
| AUTL | Autolus Therapeutics PLCspon ads | $8,686,000 | -22.9% | 699,352 | 0.0% | 0.26% | +22.0% | |
| SNAP | Snap Inccl a | $8,275,000 | +10.5% | 523,710 | 0.0% | 0.25% | +75.4% | |
| MWK | Mohawk Group Hldgs Inc | $8,258,000 | -3.1% | 1,055,954 | 0.0% | 0.25% | +53.1% | |
| CRWD | Crowdstrike Hldgs Inccl a | $8,163,000 | -14.6% | 140,000 | 0.0% | 0.24% | +35.4% | |
| GRTS | Gritstone Oncology Inc | $8,022,000 | -22.5% | 929,022 | 0.0% | 0.24% | +23.0% | |
| CRTX | Sell | Cortexyme Inc | $7,781,000 | -59.7% | 312,102 | -31.2% | 0.23% | -36.1% |
| IDYA | Ideaya Biosciences Inc | $6,779,000 | -9.6% | 753,187 | 0.0% | 0.20% | +43.7% | |
| EVLO | Evelo Biosciences Inc | $6,469,000 | -32.1% | 1,060,495 | 0.0% | 0.19% | +7.2% | |
| FULC | New | Fulcrum Therapeutics Inc | $4,743,000 | – | 714,285 | +100.0% | 0.14% | – |
| CLDR | Cloudera Inc | $3,790,000 | +68.4% | 427,710 | 0.0% | 0.11% | +165.1% | |
| ALEC | Sell | Alector Inc | $2,848,000 | -87.2% | 197,475 | -83.2% | 0.09% | -79.7% |
| SQ | Square Inccl a | $765,000 | -14.5% | 12,342 | 0.0% | 0.02% | +35.3% | |
| SPGI | New | S&P Global Inc | $318,000 | – | 1,297 | +100.0% | 0.01% | – |
| DBX | Dropbox Inccl a | $263,000 | -19.3% | 13,033 | 0.0% | 0.01% | +33.3% | |
| DOCU | Exit | DocuSign Inc | $0 | – | -411,009 | -100.0% | -0.39% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 10-Q | 2024-04-26 |
| 144 | 2024-04-26 |
| 4 | 2024-04-26 |
| 4 | 2024-04-26 |
| ARS | 2024-04-26 |
| DEF 14A | 2024-04-26 |
| DEFA14A | 2024-04-26 |
| 8-K | 2024-04-25 |
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.